The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Prevalence of Depression in Breast Cancer Survivors: a Systematic Review of Observational Studies
Open accessAbstract
BACKGROUND: Depression is common in breast cancer patients. The aim of this paper was to make a systematic review of its prevalence and associated factors oin breast cancer survivors. MATERIALS AND METHODS: An extensive systematic electronic review (PUBMED, CINAHL, PsyINFO and Ovid) and handsearch were carried out to retrieve published articles up to November 2012, using Depression OR Dysthymia AND (Cancer OR Tumor OR Neoplasms as the keywords. Information about the design of the studies, measuring scale, characteristics of the participants, prevalence of depression and its associated factors from the included studies were extracted and summarized. RESULTS: We identified 32 eligible studies that recruited 10,826 breast cancer survivors. Most were cross-sectional or prospective designed. The most frequent instrument used to screen depression was the Center for Epidemiological Studies for Depression (CES-D, n=11 studies) followed by the Beck Depression Inventory (BDI, n=6 studies) and the Hospital Anxiety and Depression Scale (HADS, n=6 studies). CES-D returned about similar prevalence of depression (median=22%, range=13-56%) with BDI (median=22%, range=17-48%) but higher than HADS (median=10%, range=1-22%). Depression was associated with several socio-demographic variables, cancer-related factors, treatment-related factors, subject psychological factors, lifestyle factors, social support and quality of life. CONCLUSIONS: Breast cancer survivors are at risk for depression so that detection of associated factors is important in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent reviews by Zainal et al. (2013) and Maass et al. (2015) determined that the prevalence of depression and anxiety in breast cancer survivors varies from 6% to 56% and 17,9% to 33,3%, respectively.”
From A guided internet-delivered individually-tailored ACT-influenced cognitive behavioural intervention to improve psychosocial outcomes in breast cancer survivors (iNNOVBC): Study protocol (2019) · cites this paper as Zainal et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When compared to the general female population, the prevalence of depression was found to be higher and persistent over >5 years after diagnosis, while the prevalence of anxiety was considered equivalent to results exhibited by the general female population.”
From A guided internet-delivered individually-tailored ACT-influenced cognitive behavioural intervention to improve psychosocial outcomes in breast cancer survivors (iNNOVBC): Study protocol (2019) · cites this paper as Zainal et al., 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life.
Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.743 · Cited by 1,134 · cited 4×
“Common physical symptom in cancer patients such as fatigue which can be symptom of the disease progression but also the common adverse effects of radiotherapy or chemotherapy was frequently reported to be associated with depression (Bower et al., 2000; 2011; Den Oudsten et al., 2009; Vahdaninia et al., 2010).”
BackgroundInfluentialColeman, M. P., Forman, D., Bryant, H., Butler, J., Rachet, B., Maringe, C., Nur, U., Tracey, E. A., Coory, M. D., Hatcher, J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62231-3 · Cited by 1,114 · cited 6×
“Social support was examined in several studies which report a significant association with depression i.e. poor social support (Mehnert and Koch, 2008; Den Oudsten et al., 2009), being unaccompanied by spouse and requested for help from psychologist (Karakoyun-Celik et al., 2010).”
InfluentialHoward-Anderson, J., Ganz, P. A., Bower, J. E., & Stanton, A. L. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr541 · Cited by 830 · cited 1×
“This is also the period whereby survivors may be at risk of developing long-term physical and psychological complications of the disease and/ or its array of treatment including mastectomy, radiotherapy and chemotherapy (Howard-Anderson et al., 2012).”
BackgroundMeasurement of depressive symptoms in cancer patients
Hann, D., Winter, K., & Jacobsen, P. (1999) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(99)00004-5 · Cited by 822 · cited 2×
“CES-D has been reported as a valid and reliable tool to screen depression in breast cancer patients (Hann et al., 1999) and demonstrates the same general structure of responses in different ethnic groups (Makambi et al.”
Influence of psychological response on survival in breast cancer: a population-based cohort study
Watson, M., Haviland, J., Greer, S., Davidson, J., & Bliss, J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11392-2 · Cited by 705 · cited 4×
“Other illness-related factors included reduced chance of survival (Watson et al., 1999), increased cortisol level at 2100 hours (Hsiao et al., 2012) and high co-morbidity index (Chen et al., 2009).”
InfluentialMajor depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586 · cited 2×
“A good review of this topic was conducted systematically (Fann et al., 2008) but did not focus on depression during survivorship; rather it looked at depression at no specific point of the disease.”
BackgroundBower, J. E., Ganz, P. A., Irwin, M. R., Kwan, L. C., Breen, E. C., & Cole, S. W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.1154 · Cited by 514 · cited 4×
“Beside fatigue, other physical symptoms associated with depression were pain (Vahdaninia et al., 2010), sleep disturbance (Bower et al., 2011) and low sexual desire (Speer et al., 2005).”
BackgroundInfluential
Research works printed but not linked: 4
- 2004, Oncol Nurs Forum, 31, 5591
- 2012, Psychooncology, 22, 922
- 2011, Radiol Technol, 83, 63
- 2012, Cancer Manag Res, 4, 61
Cited by
Sorted by citations
Awareness and current knowledge of breast cancer
Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017) · Biological Research · doi:10.1186/s40659-017-0140-9 · Cited by 1,554
“Depression is most commonly found in women with breast cancer [76].”
BackgroundRunowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3809 · Cited by 1,071
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens‐Alvarado, R. L., Cannady, R. S., Pratt‐Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21319 · Cited by 728
“In a systematic review of observational studies, the prevalence of depression and anxiety specifically among breast cancer survivors was 22% (range, 13%56%) using the Center for Epidemiological Studies for Depression, 22% (range, 17%-48%) using the Beck Depression Inventory, and 10% (range, 1%-22%) using the Hospital…”
Maass, S. W. M. C., Roorda, C., Berendsen, A. J., Verhaak, P. F. M., & de Bock, G. H. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.04.010 · Cited by 420
Carreira, H., Williams, R., Müller, M., Harewood, R., Stanway, S., & Bhaskaran, K. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy177 · Cited by 416
“Other systematic reviews on the topic assessed the prevalence of anxiety and depressive symptoms in cancer survivors (11,116–118), including studies without a comparison group.”
Background
Metadata
- Authors
- Zainal, N. Z., Nik-Jaafar, N. R., Baharudin, A., Sabki, Z. A., & Ng, C. G.
- Affiliations
- University of Malaya (MY)
- University Kebangsaan Malaysia Medical Centre (MY)
- Venue
- Asian Pacific Journal of Cancer Prevention
- Published
- 2013-04-30
- Volume
- 14
- Issue
- 4
- Pages
- 2649-2656
- ISSN
- 1513-7368 (ISSN-L)
- OpenAlex
- W2107370237
- Cited by
- 204
- References
- 56
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 17 · 2023: 17 · 2022: 20 · 2021: 20 · 2020: 22 · 2019: 24 · 2018: 15 · 2017: 15 · 2016: 12 · 2015: 15 · 2014: 13 · 2013: 1
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Asian Pacific Journal of Cancer Prevention (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Keywords
- depression, breast cancer survivors, prevalence, risk factors, depression screening, CES-D, Beck Depression Inventory, Hospital Anxiety and Depression Scale, social support, quality of life, lifestyle factors, cancer treatment effects
- MeSH terms
- Adult, Aged, Aged, 80 and over, Breast Neoplasms, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Obesity, Prognosis, Receptors, Estrogen, Receptors, Progesterone, Retrospective Studies, Body Mass Index, Survival Rate, Erb-b2 Receptor Tyrosine Kinases, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
